121-130 of 639 results
Interlocutory injunction refused based on 'doubtful' patent term extension
In the fight against patent infringement, challenging the validity of patent term extensions (PTEs) is increasingly becoming the weapon of choice for generic pharmaceutical companies. Since around the mid-2000s, patentees in pharmaceutical patent cases have typically been successful in bids for interlocutory injunctions, aiming to prevent the launch of generic products in Australia. The recent Biogen decision by the Federal Court is the latest in a trend of refusing interlocutory injunctions, and a clear indication the tide is turning. ...
Antibody patent protection in Australia
Many of the top selling drugs in Australia are antibodies, all part of a global market estimated to reach US$140 billion this year. Recently, the US FDA (Food and Drug Administration) approved the ...
Allens advises LAVO on world-first hydrogen energy storage system
The LAVO HESS – which took three wins at Australia's Good Design Awards and was showcased at the COP26 Climate Summit in Glasgow – is now being commercialised in a world-first first hydrogen energy ...
Worth the wait? Release of draft mandatory data breach notification laws
Following a period of industry consultation the Federal Government has introduced updated legislation that will introduce a mandatory data breach notification scheme The new Bill will amend the Privacy Act 1988 Cth when it comes into force and will apply to all Australian companies currently subject ...
Allens advises on sale of Playground XYZ
Playground XYZ is a client of Allens' Accelerate practice, which was the first dedicated startups and scaleups practice from a major law firm in Australia. 'We are delighted to have assisted the ...
Nucleus – corporate law developments: virtual meetings and e-signing lead a raft of changes coming in 2022
After an extremely busy end to the year, we are pleased to present our snapshot of corporate law developments to the end of 2021. We wish you all the very best for the Christmas and New Year break, and look forward to bringing you further developments through Nucleus in 2022. ...
Allens advises Canopus Networks on $10 million capital raise
The new funding will allow Canopus Networks to accelerate its growth and expand into 5G, gaming and international markets. 'We are delighted to have assisted Canopus on this transaction given our ...
Lessons on product branding and trade mark use in the context of halal certification
In Halal Certification Authority v Flujo Sanguineo Holdings, the court dismissed Halal Certification Authority Pty Ltd's (HCA) claims of trade mark infringement, misleading or deceptive conduct and passing off against the Flujo Group of companies relating to the use of a halal-related trade mark, and ordered that its registration for that mark be cancelled. ...
Managing the risks of brand collaborations – a few top tips
Brand collaborations can create exciting commercial opportunities for businesses. However, they involve a number of risks. These include, for example, the possibility that a collaborator may suffer unexpected damage to their brand which makes the collaboration no longer commercially viable. Therefor ...
Overcoming roadblocks to blockchain inventions
In welcome news for technology innovators, a delegate of the Commissioner of Patents recently determined that certain blockchain inventions constituted patentable subject matter. ...